Hemp & Health S.A. (WSE:HMP)
Poland · Delayed Price · Currency is PLN 3.650
-0.130 (-3.44%)
At close: Jul 24, 2026
Hemp & Health Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Transaction-Based Revenues | 0.2 | 0.21 | 0.13 | 0.27 | 1.07 | 3.34 |
Other Revenues | - | 0 | 0.01 | 0.19 | 0.54 | - |
| 0.2 | 0.21 | 0.14 | 0.46 | 1.62 | 3.34 | |
Revenue Growth (YoY) | 41.56% | 49.18% | -69.76% | -71.31% | -51.67% | 2218.19% |
Cost of Revenue | 0.32 | 0.35 | 0.28 | 0.31 | 1.05 | 2.49 |
Gross Profit | -0.12 | -0.14 | -0.14 | 0.15 | 0.57 | 0.86 |
Selling, General & Admin | 1.05 | 1.19 | 0.89 | 0.67 | 0.78 | 0.67 |
Depreciation & Amortization Expenses | 0.1 | 0.1 | 0.06 | 0.04 | 0 | - |
Other Operating Expenses | 0 | 0 | 0.06 | 0.17 | 0.34 | 0.53 |
Operating Income | -1.27 | -1.44 | -1.15 | -0.73 | -0.55 | -0.34 |
Interest Income | 0.11 | 0.12 | 0.19 | 0.1 | 0 | - |
Interest Expense | - | 0 | 0 | -0 | -0.04 | -0.01 |
Other Non-Operating Income (Expense) | -0.07 | -0.07 | -0.06 | -0.27 | -2.33 | 0.18 |
Total Non-Operating Income (Expense) | 0.03 | 0.05 | 0.13 | -0.17 | -2.36 | 0.17 |
Pretax Income | -1.24 | -1.39 | -1.03 | -0.89 | -2.91 | -0.17 |
Net Income | -1.24 | -1.39 | -1.03 | -0.84 | -2.91 | -0.17 |
Net Income to Common | -1.24 | -1.39 | -1.03 | -0.84 | -2.91 | -0.17 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 8 | 79 | 72 | 72 | 29 | 29 |
Shares Outstanding (Diluted) | 8 | 79 | 72 | 72 | 29 | 29 |
Shares Change (YoY) | -89.60% | 9.70% | - | 147.48% | - | 7.95% |
EPS (Basic) | -0.16 | -0.02 | -0.01 | -0.02 | -0.02 | -0.01 |
EPS (Diluted) | -0.16 | -0.02 | -0.01 | -0.02 | -0.02 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -1.2 | -1.47 | -1.03 | -0.64 | 0.04 | -0.82 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.15 | -0.02 | -0.01 | -0.01 | 0.00 | -0.03 |
Gross Margin | -61.95% | -68.46% | -100.01% | 32.51% | 35.11% | 25.62% |
Operating Margin | -648.39% | -686.70% | -823.21% | -156.92% | -34.04% | -10.20% |
Profit Margin | -632.27% | -664.59% | -733.79% | -181.85% | -180.13% | -5.19% |
FCF Margin | -609.92% | -705.01% | -737.97% | -138.43% | 2.33% | -24.64% |
EBITDA | -1.17 | -1.33 | -1.09 | -0.69 | -0.55 | -0.34 |
EBITDA Margin | -595.77% | -637.26% | -779.97% | -149.17% | -34.04% | -10.20% |
EBIT | -1.27 | -1.44 | -1.15 | -0.73 | -0.55 | -0.34 |
EBIT Margin | -648.39% | -686.70% | -823.21% | -156.92% | -34.04% | -10.20% |